Pfizer and BioNTech receive U.S. FDA Emergency Use Authorization of COVID-19 vaccine booster for individuals 12 years of age and older
- Details
- Category: Pfizer
![Pfizer Pfizer](/images/logo/pfizer.png)
AstraZeneca and Ionis close agreement to develop and commercialise eplontersen
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](/images/logo/astrazeneca.png)
The companies will jointly develop and commercialise eplontersen in the US, while AstraZeneca will develop and commercialise it in the rest of the world, except in Latin America.
Vaxzevria significantly boosted antibody levels against Omicron
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](/images/logo/astrazeneca.png)
Neutralisation titres for Omicron were boosted following a third dose with Vaxzevria compared to titres after a second dose.(1)
European Commission grants conditional marketing authorization for Novavax COVID-19 vaccine
- Details
- Category: Business
![Novavax, Inc. Novavax, Inc.](/images/logo/novavax.png)
Evusheld long-acting antibody combination retains neutralising activity against Omicron variant in independent FDA study
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](/images/logo/astrazeneca.png)
In this study, Evusheld's Inhibitory Concentration 50 (IC50), a measure of neutralising potency of an antibody, was 171 ng/ml and 277 ng/ml in two confirmatory tests, which is within the range of neutralising titres found in someone who has been previously infected with COVID-19.
Novartis announces T-Charge™, next-generation CAR-T platform with first-in-human data at ASH 2021
- Details
- Category: Novartis
![Novartis Novartis](/images/logo/novartis.png)
Medicago and GSK announce positive Phase 3 efficacy and safety results for adjuvanted plant-based COVID-19 vaccine candidate
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline GlaxoSmithKline](/images/logo/gsk.png)
More Pharma News ...
- EUR 50 million for social businesses - Boehringer Ingelheim launches Boehringer Ingelheim Social Engagements
- Pfizer and BioNTech provide update on Omicron variant
- Roche completed the repurchase of Roche shares from Novartis
- GSK and the University of Oxford launch new Oxford-GSK Institute to harness advanced technology and unravel mechanisms of disease
- AWS helps Pfizer accelerate drug development and clinical manufacturing
- GSK unveils Target the Future, a global, multi-year programme to help address key challenges affecting the multiple myeloma community
- Sanofi invests $180 million equity in Owkin's artificial intelligence and federated learning to advance oncology pipeline